Analysis
Riber 2011 first-quarter revenues
RIBER, the global leader for molecular beam epitaxy (MBE), recorded €5.7 million in revenues for the first quarter of 2011, up 98% in relation to the first quarter of 2010, with its order book climbing 134% compared with last year to €21.3 million.
GrowSales of services and accessories are down temporarily compared with the high level seen in the first quarter of 2010. The positive evolution of revenues also results from Riber’s policy aiming to evenly spread production throughout the year. Strong outlook for 2011 The order book at the end of March 2011 came to €21.3 million, 134% higher than the same period in 2010. It consists of six research systems and four production systems, with the company receiving an order for a new production machine in March. Out of these 10 machines in the order book, only one system is not scheduled to be delivered during the year. In addition, the book includes major effusion cell orders in the OLED sector.